- Home
- DHY vs NGNE Comparison
DHY vs NGNE Comparison
Compare DHY & NGNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DHY
- NGNE
- Stock Information
- Founded
- DHY 1998
- NGNE 2003
- Country
- DHY United States
- NGNE United States
- Employees
- DHY N/A
- NGNE N/A
- Industry
- DHY Finance/Investors Services
- NGNE Biotechnology: Pharmaceutical Preparations
- Sector
- DHY Finance
- NGNE Health Care
- Exchange
- DHY Nasdaq
- NGNE Nasdaq
- Market Cap
- DHY 221.6M
- NGNE 230.0M
- IPO Year
- DHY N/A
- NGNE N/A
- Fundamental
- Price
- DHY $2.16
- NGNE $17.36
- Analyst Decision
- DHY
- NGNE Strong Buy
- Analyst Count
- DHY 0
- NGNE 6
- Target Price
- DHY N/A
- NGNE $60.80
- AVG Volume (30 Days)
- DHY 569.1K
- NGNE 277.9K
- Earning Date
- DHY 01-01-0001
- NGNE 11-18-2024
- Dividend Yield
- DHY 9.10%
- NGNE N/A
- EPS Growth
- DHY N/A
- NGNE N/A
- EPS
- DHY N/A
- NGNE N/A
- Revenue
- DHY N/A
- NGNE $925,000.00
- Revenue This Year
- DHY N/A
- NGNE N/A
- Revenue Next Year
- DHY N/A
- NGNE N/A
- P/E Ratio
- DHY N/A
- NGNE N/A
- Revenue Growth
- DHY N/A
- NGNE N/A
- 52 Week Low
- DHY $1.77
- NGNE $14.42
- 52 Week High
- DHY $2.08
- NGNE $74.49
- Technical
- Relative Strength Index (RSI)
- DHY 54.78
- NGNE 44.25
- Support Level
- DHY $2.12
- NGNE $16.72
- Resistance Level
- DHY $2.19
- NGNE $19.97
- Average True Range (ATR)
- DHY 0.02
- NGNE 2.39
- MACD
- DHY 0.00
- NGNE 0.08
- Stochastic Oscillator
- DHY 80.00
- NGNE 19.43
About DHY Credit Suisse High Yield Bond Fund
Credit Suisse High Yield Bond Fund is a non-diversified, closed-end management investment company to seeks high current income and capital appreciation as a secondary objective.
About NGNE Neurogene Inc.
Neurogene Inc is a clinical stage biotechnology company whose objective is to harness the power of gene therapy which is combined with its EXACT gene regulation technology to turn today's complex devastating neurological diseases into treatable conditions.